02/27/2013
IRVINE, California—Endologix, Inc. (NASDAQ: ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and twelve months ended December 31, 2012.
John McDermott, Endologix President and Chief Executive Officer, said, “In 2012 we achieved another year of strong revenue growth driven by continued…
02/19/2013
New York, NY—Essex Woodlands, a leading healthcare growth equity firm with a global investment practice, has announced the addition of Ms. Cecilia Gonzalo as Managing Director to their healthcare investment team. Ms. Gonzalo has 15 years of experience in healthcare investing and international finance and a successful investment track record…
01/04/2013
HOUSTON, TEXAS—Essex Woodlands, a leading healthcare growth equity firm with a global investment practice, has announced, effective January 1, 2013, the promotion of five key investment professionals in their Shanghai, London and New York offices. Scott Barry and David Yang were promoted to Managing Director in Shanghai, Toby Sykes to…
01/02/2013
PALO ALTO, California—Open Monoclonal Technology Inc. has created three subsidiaries that it’s looking to sell as part of its unusual strategy to succeed at a tough time for biotechnology startups, VentureWire has learned.
Open Monoclonal plans to begin selling the subsidiaries this year to corporations seeking unlimited access…
12/21/2012
DEERFIELD, IL—Horizon Pharma, Inc. ( NASDAQ : HZNP ) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA), based on the favorable recommendation of their Commission on Human Medicines (CHM), will grant a Marketing Authorization (MA) for DUEXIS® (ibuprofen/famotidine), pending review of updated licensing documents…